drugset / Trial / NCT07221838
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, multicenter single arm study designed to evaluate the effectiveness and safety of a predefined oral corticosteroids (OCS) tapering schedule to reduce OCS use in adult participants with acetylcholine receptor positive (AChR+) generalized myasthenia gravis (gMG) being treated with intravenous ravulizumab.
Timeline
- Start
- 2026-03-04
- Primary completion
- 2027-08-27
- Completion
- 2027-08-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisolone | Other / unclassified | — | Oral |
| Subject | Prednisone | Other / unclassified | — | Oral |
| Background | Ravulizumab | Monoclonal antibody | — | Intravenous |